Dr. Shigenobu Suzuki Opthalmic Oncology


Consultant - Opthalmic Oncology , Experience:

Book Appointment

About Doctor

Dr. Shigenobu Suzuki is among the top eye cancer specialist in Tokyo, Japan.

Dr. Shigenobu Suzuki is associated with National Cancer Centre Hospital, Japan.

The Department of Ocular Oncology is one of the rare groups specializing in ocular tumors, especially intraocular tumors. Recently, more than 70% of patients nationwide with retinoblastoma, which is the most frequent intraocular malignancy in childhood, and more than 50% of patients with choroidal melanoma, which is the most frequent primary intraocular malignancy in adults, have been referred to our department. We also treat ocular adnexal tumors. More than 350 operations have been done annually.

We are participating in clinical trials by estimating ocular adverse events of systemic chemotherapy. Recent molecular target therapy sometimes cause macular edema, serous retinal detachment, uveitis, ocular surface disease, and so on, and we evaluate and treat these adverse events to contribute clinical trials.

Hospital

National Cancer Centre, Japan

Specialization

  • Opthalmic Oncology

Procedures Performed

  • Opthalmic Oncology
  • Retinoblastoma
  • Macular edema
  • Choroidal melanoma

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy